{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:20:28Z","timestamp":1789600828477,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,21]]},"DOI":"10.7759\/cureus.28230","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T14:20:46Z","timestamp":1661091646000},"source":"Crossref","is-referenced-by-count":34,"title":["Prevention and Treatment of Monkeypox: A Step-by-Step Guide for Healthcare Professionals and General Population"],"prefix":"10.7759","author":[{"given":"Lokesh","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Ajmera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Smallpox & other orthopoxvirus-associated infections","author":"McCollum AM","year":"2020","unstructured":"McCollum AM. Smallpox & other orthopoxvirus-associated infections. Travel-related infectious diseases. CDC, 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos AM","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, et al.. A tale of two clades: monkeypox viruses. J Gen Virol. 2005, 86:2661-72. 10.1099\/vir.0.81215-0","journal-title":"J Gen Virol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in cynomolgus monkeys","volume":"46","author":"Magnus PV","year":"1959","unstructured":"Magnus PV, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Pathologica Microbiologica Scandinavica. 1959, 46:156-76.","journal-title":"Acta Pathologica Microbiologica Scandinavica"},{"key":"ref4","article-title":"Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin","volume":"52","year":"2003","unstructured":"Update. multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin. Centers for Disease Control and Prevention. 2003, 52:642-6.","journal-title":"Centers for Disease Control and Prevention"},{"key":"ref5","unstructured":"Multi-country monkeypox outbreak in non-endemic countries. (2022). Accessed. 2022: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON385."},{"key":"ref6","unstructured":"2022 Monkeypox Outbreak. (2022). Accessed. 2022 Aug 8: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html."},{"key":"ref7","unstructured":"Monkeypox cases reported in UK and Portugal. (2022). Accessed. 2022: https:\/\/www.ecdc.europa.eu\/en\/news-events\/monkeypox-cases-reported-uk-and-portugal."},{"key":"ref8","unstructured":"Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox. (2022). Accessed. 2022: https:\/\/www.who.int\/news\/item\/23-07-2022-second-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergenc...."},{"key":"ref9","article-title":"Epidemiology, diagnosis, and control of monkeypox disease: a comprehensive review","volume":"5","author":"Pal M","year":"2017","unstructured":"Pal M, Mengstie F, Kandi V. Epidemiology, diagnosis, and control of monkeypox disease: a comprehensive review. Am J Infect Dis. 2017, 5:94-9.","journal-title":"Am J Infect Dis"},{"key":"ref10","unstructured":"CDC and health partners responding to monkeypox case in the U.S.. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/media\/releases\/2022\/s0518-monkeypox-case.html."},{"key":"ref11","unstructured":"Multi-country monkeypox outbreak in non-endemic countries. (2022). Accessed. 2022: https:\/\/www.who.int\/health-topics\/monkeypox#tab=tab_1."},{"key":"ref12","unstructured":"How it spreads. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/transmission.html."},{"key":"ref13","unstructured":"Potential exposure to person with confirmed human monkeypox infection - United States, 2021. (2021). Accessed. 2022: https:\/\/emergency.cdc.gov\/han\/2021\/han00446.asp."},{"key":"ref14","unstructured":"Monkeypox. (2022). Accessed. 2022: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102855","article-title":"The 2022 outbreak and the pathobiology of the monkeypox virus","volume":"131","author":"Kumar N","year":"2022","unstructured":"Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022, 131:102855. 10.1016\/j.jaut.2022.102855","journal-title":"J Autoimmun"},{"key":"ref16","article-title":"Viral infections with cutaneous lesions","year":"2013","unstructured":"Viral infections with cutaneous lesions. Hunter's tropical medicine and emerging infectious disease. Elsevier, 2013. 251-68. https.\/\/doi.org\/10.1016\/B978-1-4160-4390-4.00170-3"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7123e1","article-title":"Monkeypox outbreak - nine states, May 2022","volume":"71","author":"Minhaj FS","year":"2022","unstructured":"Minhaj FS, Ogale YP, Whitehill F, et al.. Monkeypox outbreak - nine states, May 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:764-9. 10.15585\/mmwr.mm7123e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01587","article-title":"Monkeypox\u00a0- an emerging pandemic","volume":"29","author":"Ajmera KM","year":"2022","unstructured":"Ajmera KM, Goyal L, Pandit T, Pandit R. Monkeypox\u00a0- an emerging pandemic. IDCases. 2022, 29:e01587. 10.1016\/j.idcr.2022.e01587","journal-title":"IDCases"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","author":"Thornhill JP","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, et al.. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022, 10.1056\/NEJMoa2207323","journal-title":"N Engl J Med"},{"key":"ref20","unstructured":"Prevention. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/prevention.html."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox, and risk factors for severe disease","volume":"41","author":"Huhn GD","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K, et al.. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005, 41:1742-51. 10.1086\/498115","journal-title":"Clin Infect Dis"},{"key":"ref22","unstructured":"WHO. 14,000 monkeypox cases worldwide, 5 deaths. (2022). Accessed: 2022: https:\/\/www.cidrap.umn.edu\/news-perspective\/2022\/07\/who-14000-monkeypox-cases-worldwide-5-deaths."},{"key":"ref23","unstructured":"Treatment information for healthcare professionals. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.7.867-872.2005","article-title":"Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak","volume":"12","author":"Karem KL","year":"2005","unstructured":"Karem KL, Reynolds M, Braden Z, Lou G, Bernard N, Patton J, Damon IK. Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol. 2005, 12:867-72. 10.1128\/CDLI.12.7.867-872.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins J","year":"2009","unstructured":"Huggins J, Goff A, Hensley L, et al.. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother. 2009, 53:2620-5. 10.1128\/AAC.00021-09","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","unstructured":"CDC public health image library. (2003). Accessed. 2022: https:\/\/phil.cdc.gov\/details.aspx?pid=22664."},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3201\/eid1211.060618","article-title":"Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies","volume":"12","author":"Cono J","year":"2006","unstructured":"Cono J, Cragan JD, Jamieson DJ, Rasmussen SA. Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis. 2006, 12:1631-7.","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker RO","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003, 57:13-23.","journal-title":"Antiviral Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy KC","year":"1999","unstructured":"Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet. 1999, 36:127-43. 10.2165\/00003088-199936020-00004","journal-title":"Clin Pharmacokinet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/095632020801900302","article-title":"Progress in the discovery of compounds inhibiting orthopoxviruses in animal models","volume":"19","author":"Smee DF","year":"2008","unstructured":"Smee DF. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Antivir Chem Chemother. 2008, 19:115-24. 10.1177\/095632020801900302","journal-title":"Antivir Chem Chemother"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00927-20","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson CL","year":"2021","unstructured":"Hutson CL, Kondas AV, Mauldin MR, et al.. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere. 2021, 6:10.1128\/mSphere.00927-20","journal-title":"mSphere"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/v3010047","article-title":"Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice AD","year":"2011","unstructured":"Rice AD, Adams MM, Wallace G, et al.. Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans. Viruses. 2011, 3:47-62. 10.3390\/v3010047","journal-title":"Viruses"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler H","year":"2022","unstructured":"Adler H, Gould S, Hine P, et al.. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022, 22:1153-62. 10.1016\/S1473-3099(22)00228-6","journal-title":"Lancet Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.715","article-title":"The ocular complications of smallpox and smallpox immunization","volume":"121","author":"Semba RD","year":"2003","unstructured":"Semba RD. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol. 2003, 121:715-9. 10.1001\/archopht.121.5.715","journal-title":"Arch Ophthalmol"},{"key":"ref35","unstructured":"Clinical recognition. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/clinical-recognition.html."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox - a potential threat? A systematic review","volume":"16","author":"Bunge EM","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox - a potential threat? A systematic review. PLoS Negl Trop Dis. 2022, 16:e0010141. 10.1371\/journal.pntd.0010141","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1748","article-title":"Monkeypox: avoiding the mistakes of past infectious disease epidemics","volume":"175","author":"Daskalakis D","year":"2022","unstructured":"Daskalakis D, McClung RP, Mena L, Mermin J. Monkeypox: avoiding the mistakes of past infectious disease epidemics. Ann Intern Med. 2022, 175:1177-8. 10.7326\/M22-1748","journal-title":"Ann Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3539","article-title":"Monkeypox outbreak - no panic and stigma; only awareness and preventive measures can halt the pandemic turn of this epidemic infection","author":"Rabiul Islam M","year":"2022","unstructured":"Rabiul Islam M, Hasan M, Rahman MS, Rahman MA. Monkeypox outbreak - no panic and stigma; only awareness and preventive measures can halt the pandemic turn of this epidemic infection. Int J Health Plann Manage. 2022, 10.1002\/hpm.3539","journal-title":"Int J Health Plann Manage"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13785","article-title":"Monkeypox 2022 outbreak: an update","volume":"27","author":"Velavan TP","year":"2022","unstructured":"Velavan TP, Meyer CG. Monkeypox 2022 outbreak: an update. Trop Med Int Health. 2022, 27:604-5. 10.1111\/tmi.13785","journal-title":"Trop Med Int Health"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13798","article-title":"Monkeypox outbreak: preventing another episode of stigmatisation","author":"Chang CT","year":"2022","unstructured":"Chang CT, Thum CC, Lim XJ, Chew CC, Rajan P. Monkeypox outbreak: preventing another episode of stigmatisation. Trop Med Int Health. 2022, 10.1111\/tmi.13798","journal-title":"Trop Med Int Health"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001356","article-title":"Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin","volume":"5","author":"Roess AA","year":"2011","unstructured":"Roess AA, Monroe BP, Kinzoni EA, et al.. Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin. PLoS Negl Trop Dis. 2011, 5:e1356. 10.1371\/journal.pntd.0001356","journal-title":"PLoS Negl Trop Dis"},{"key":"ref42","unstructured":"Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/considerations-for-monkeypox-vaccination.html."},{"key":"ref43","unstructured":"Orthopoxvirus vaccine guidance for persons at risk for occupational exposure. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/occupational-exposures\/orthopoxvirus-vaccine-guidance.html."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.06.047","article-title":"Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3","volume":"122","author":"Petersen E","year":"2022","unstructured":"Petersen E, Zumla A, Hui DS, et al.. Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3. Int J Infect Dis. 2022, 122:569-71. 10.1016\/j.ijid.2022.06.047","journal-title":"Int J Infect Dis"},{"key":"ref45","unstructured":"2022 monkeypox outbreak global map. (2022). Accessed. 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195897","article-title":"Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: a randomised, double blind, placebo controlled phase III trial","volume":"13","author":"Overton ET","year":"2018","unstructured":"Overton ET, Lawrence SJ, Wagner E, et al.. Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: a randomised, double blind, placebo controlled phase III trial. PLoS One. 2018, 13:e0195897. 10.1371\/journal.pone.0195897","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein","volume":"9","author":"Cooney EL","year":"1991","unstructured":"Cooney EL, Collier AC, Greenberg PD, et al.. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet. 1991, 9:567-72. 10.1016\/0140-6736(91)91636-9","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Rao AK","year":"2022","unstructured":"Rao AK, Petersen BW, Whitehill F, et al.. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:734-42. 10.15585\/mmwr.mm7122e1","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110751-prevention-and-treatment-of-monkeypox-a-step-by-step-guide-for-healthcare-professionals-and-general-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:27Z","timestamp":1707507567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110751-prevention-and-treatment-of-monkeypox-a-step-by-step-guide-for-healthcare-professionals-and-general-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,21]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.28230","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,21]]}}}